Share Price and Basic Stock Data
Last Updated: January 23, 2026, 5:02 pm
| PEG Ratio | 0.98 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Lumax Industries Ltd operates in the auto ancillary sector, specializing in equipment lamps. The company’s share price stood at ₹4,792, with a market capitalization of ₹4,478 Cr. In the fiscal year ending March 2023, Lumax reported sales of ₹2,320 Cr, reflecting a significant increase from ₹1,751 Cr in the previous year. The company demonstrated a robust growth trajectory, as revenue rose to ₹2,637 Cr in FY 2024 and is projected to reach ₹3,400 Cr in FY 2025. Quarterly sales figures also indicate a positive trend, with the latest reported sales for September 2023 at ₹644 Cr, an increase from ₹618 Cr in June 2023. This consistent revenue growth underscores Lumax’s ability to capitalize on market opportunities within the automotive sector, which is recovering steadily post-pandemic.
Profitability and Efficiency Metrics
Lumax Industries reported a net profit of ₹149 Cr for the fiscal year ending March 2023, up from ₹103 Cr in FY 2022. The company’s operating profit margin (OPM) stood at 9% for FY 2023, slightly lower than the previous year’s 8%. However, OPM trends in quarterly results showed fluctuations, with a peak of 9% in September 2023. The return on equity (ROE) was notably strong at 19.3%, while the return on capital employed (ROCE) stood at 16.4%, indicating efficient utilization of capital. The company’s interest coverage ratio (ICR) of 3.99x suggests a healthy ability to meet interest obligations, although a slight decline from previous years might warrant monitoring. Overall, Lumax’s profitability metrics reflect a solid operational framework, though maintaining a high OPM will be crucial as expenses continue to rise.
Balance Sheet Strength and Financial Ratios
Lumax Industries’ balance sheet reflects a growing asset base with total assets reported at ₹2,861 Cr as of March 2025, up from ₹2,601 Cr in the previous year. The equity capital has remained stable at ₹9 Cr, while reserves increased to ₹806 Cr, indicating a healthy retained earnings policy. However, borrowings have also risen to ₹989 Cr, reflecting a higher leverage ratio, with total debt to equity standing at 0.99x. The company’s current ratio of 0.75 indicates potential liquidity concerns, as it is below the 1.0 mark, which is typically considered a healthy benchmark. Nevertheless, the inventory turnover ratio of 6.22x suggests efficient inventory management, a positive sign for operational efficiency. The book value per share increased to ₹828.32, reflecting solid underlying value creation.
Shareholding Pattern and Investor Confidence
The shareholding structure of Lumax Industries displays a strong promoter commitment, with promoters holding 75% of the equity. Institutional investors have a modest presence, with Foreign Institutional Investors (FIIs) at 1.13% and Domestic Institutional Investors (DIIs) at 5.98%. The public shareholding stands at 17.89%, indicating a reasonable distribution of shares among retail investors. The number of shareholders increased to 21,486 by September 2025, suggesting growing investor interest. However, the relatively low FII participation could imply a cautious outlook from foreign investors. The consistency in promoter holding may bolster confidence among retail investors, but increased institutional interest would enhance overall market perception and liquidity.
Outlook, Risks, and Final Insight
Looking ahead, Lumax Industries is poised for growth, driven by increasing demand in the auto ancillary sector and a focus on innovation. However, rising input costs and global supply chain disruptions pose significant risks that could impact profitability. Additionally, the company’s high leverage may constrain flexibility in capital management during downturns. The auto industry is also subject to regulatory changes that could affect operational costs. To sustain growth, Lumax must effectively manage these risks while capitalizing on emerging market opportunities. If the company can navigate these challenges successfully, it may enhance its profitability and shareholder value significantly in the coming years. Conversely, failure to address these risks could hinder its performance, making it essential for ongoing vigilance and adaptive strategies.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Varroc Engineering Ltd | 8,607 Cr. | 563 | 695/365 | 44.4 | 110 | 0.18 % | 17.1 % | 7.37 % | 1.00 |
| Uravi Defence & Technology Ltd | 223 Cr. | 197 | 588/153 | 108 | 44.2 | 0.00 % | % | % | 10.0 |
| Lumax Industries Ltd | 4,337 Cr. | 4,633 | 5,878/1,960 | 29.0 | 873 | 0.76 % | 16.4 % | 19.3 % | 10.0 |
| Fiem Industries Ltd | 5,636 Cr. | 2,145 | 2,445/1,156 | 25.1 | 410 | 1.40 % | 27.8 % | 21.0 % | 10.0 |
| Industry Average | 4,700.75 Cr | 1,884.50 | 51.63 | 359.30 | 0.59% | 20.43% | 15.89% | 7.75 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 620 | 579 | 608 | 618 | 644 | 632 | 743 | 766 | 812 | 887 | 923 | 923 | 1,009 |
| Expenses | 560 | 524 | 559 | 567 | 589 | 573 | 677 | 708 | 752 | 817 | 844 | 841 | 920 |
| Operating Profit | 60 | 56 | 49 | 51 | 55 | 58 | 66 | 58 | 60 | 70 | 79 | 82 | 89 |
| OPM % | 10% | 10% | 8% | 8% | 9% | 9% | 9% | 8% | 7% | 8% | 9% | 9% | 9% |
| Other Income | 15 | 13 | 14 | 14 | 15 | 13 | 28 | 31 | 22 | 18 | 25 | 16 | 14 |
| Interest | 7 | 8 | 9 | 10 | 11 | 13 | 15 | 16 | 19 | 19 | 18 | 18 | 19 |
| Depreciation | 20 | 20 | 21 | 21 | 21 | 24 | 27 | 26 | 26 | 27 | 33 | 32 | 37 |
| Profit before tax | 48 | 41 | 33 | 34 | 38 | 35 | 52 | 46 | 37 | 42 | 53 | 48 | 47 |
| Tax % | 31% | 27% | 38% | 32% | 31% | 27% | 31% | 26% | 23% | 19% | 18% | 25% | 24% |
| Net Profit | 33 | 30 | 21 | 23 | 26 | 26 | 36 | 34 | 28 | 33 | 44 | 36 | 36 |
| EPS in Rs | 35.27 | 31.60 | 22.20 | 24.73 | 28.08 | 27.37 | 38.59 | 36.57 | 30.25 | 35.82 | 47.04 | 38.72 | 38.13 |
Last Updated: January 11, 2026, 2:17 pm
Below is a detailed analysis of the quarterly data for Lumax Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,009.00 Cr.. The value appears strong and on an upward trend. It has increased from 923.00 Cr. (Jun 2025) to 1,009.00 Cr., marking an increase of 86.00 Cr..
- For Expenses, as of Sep 2025, the value is 920.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 841.00 Cr. (Jun 2025) to 920.00 Cr., marking an increase of 79.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 89.00 Cr.. The value appears strong and on an upward trend. It has increased from 82.00 Cr. (Jun 2025) to 89.00 Cr., marking an increase of 7.00 Cr..
- For OPM %, as of Sep 2025, the value is 9.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 9.00%.
- For Other Income, as of Sep 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Jun 2025) to 14.00 Cr., marking a decrease of 2.00 Cr..
- For Interest, as of Sep 2025, the value is 19.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.00 Cr. (Jun 2025) to 19.00 Cr., marking an increase of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 37.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 32.00 Cr. (Jun 2025) to 37.00 Cr., marking an increase of 5.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 47.00 Cr.. The value appears to be declining and may need further review. It has decreased from 48.00 Cr. (Jun 2025) to 47.00 Cr., marking a decrease of 1.00 Cr..
- For Tax %, as of Sep 2025, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Jun 2025) to 24.00%, marking a decrease of 1.00%.
- For Net Profit, as of Sep 2025, the value is 36.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 36.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 38.13. The value appears to be declining and may need further review. It has decreased from 38.72 (Jun 2025) to 38.13, marking a decrease of 0.59.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:03 am
| Metric | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,252 | 1,271 | 1,649 | 1,851 | 1,602 | 1,426 | 1,751 | 2,320 | 2,637 | 3,400 | 3,742 |
| Expenses | 1,164 | 1,170 | 1,515 | 1,698 | 1,443 | 1,326 | 1,616 | 2,112 | 2,405 | 3,120 | 3,422 |
| Operating Profit | 89 | 101 | 135 | 154 | 158 | 100 | 135 | 208 | 231 | 280 | 320 |
| OPM % | 7% | 8% | 8% | 8% | 10% | 7% | 8% | 9% | 9% | 8% | 9% |
| Other Income | 4 | 17 | 19 | 57 | 19 | 27 | 3 | 51 | 70 | 84 | 74 |
| Interest | 13 | 11 | 8 | 16 | 22 | 29 | 22 | 30 | 49 | 73 | 74 |
| Depreciation | 38 | 41 | 48 | 60 | 64 | 65 | 64 | 80 | 93 | 113 | 129 |
| Profit before tax | 41 | 65 | 98 | 134 | 92 | 33 | 53 | 149 | 159 | 178 | 190 |
| Tax % | 10% | 16% | 27% | 23% | 22% | 45% | 23% | 31% | 30% | 21% | |
| Net Profit | 52 | 54 | 71 | 104 | 72 | 18 | 41 | 103 | 111 | 140 | 149 |
| EPS in Rs | 55.66 | 58.16 | 76.34 | 111.03 | 76.92 | 19.42 | 43.56 | 110.27 | 118.77 | 149.67 | 159.71 |
| Dividend Payout % | 22% | 25% | 30% | 32% | 31% | 36% | 31% | 24% | 29% | 23% |
YoY Net Profit Growth
| Year | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 3.85% | 31.48% | 46.48% | -30.77% | -75.00% | 127.78% | 151.22% | 7.77% | 26.13% |
| Change in YoY Net Profit Growth (%) | 0.00% | 27.64% | 15.00% | -77.25% | -44.23% | 202.78% | 23.44% | -143.45% | 18.36% |
Lumax Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2016-2017 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 25% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 14% |
| 3 Years: | 38% |
| TTM: | 16% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 22% |
| 3 Years: | 37% |
| 1 Year: | 41% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 19% |
| Last Year: | 19% |
Last Updated: September 5, 2025, 9:55 am
Balance Sheet
Last Updated: December 4, 2025, 1:35 am
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 259 | 300 | 353 | 426 | 437 | 451 | 482 | 574 | 662 | 765 | 806 |
| Borrowings | 127 | 92 | 104 | 140 | 347 | 338 | 401 | 431 | 723 | 888 | 989 |
| Other Liabilities | 463 | 478 | 751 | 615 | 490 | 564 | 654 | 852 | 1,207 | 1,199 | 1,293 |
| Total Liabilities | 859 | 880 | 1,217 | 1,190 | 1,283 | 1,362 | 1,546 | 1,866 | 2,601 | 2,861 | 3,098 |
| Fixed Assets | 408 | 419 | 518 | 549 | 653 | 627 | 711 | 749 | 968 | 1,106 | 1,316 |
| CWIP | 17 | 20 | 34 | 50 | 32 | 47 | 48 | 43 | 178 | 212 | 129 |
| Investments | 69 | 79 | 88 | 81 | 90 | 92 | 102 | 147 | 179 | 246 | 272 |
| Other Assets | 365 | 362 | 577 | 510 | 508 | 596 | 685 | 927 | 1,276 | 1,297 | 1,380 |
| Total Assets | 859 | 880 | 1,217 | 1,190 | 1,283 | 1,362 | 1,546 | 1,866 | 2,601 | 2,861 | 3,098 |
Below is a detailed analysis of the balance sheet data for Lumax Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.00 Cr..
- For Reserves, as of Sep 2025, the value is 806.00 Cr.. The value appears strong and on an upward trend. It has increased from 765.00 Cr. (Mar 2025) to 806.00 Cr., marking an increase of 41.00 Cr..
- For Borrowings, as of Sep 2025, the value is 989.00 Cr.. The value appears to be increasing, which may not be favorable. However, Borrowings exceed Reserves, which may signal higher financial risk. It has increased from 888.00 Cr. (Mar 2025) to 989.00 Cr., marking an increase of 101.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,293.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,199.00 Cr. (Mar 2025) to 1,293.00 Cr., marking an increase of 94.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,098.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,861.00 Cr. (Mar 2025) to 3,098.00 Cr., marking an increase of 237.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,316.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,106.00 Cr. (Mar 2025) to 1,316.00 Cr., marking an increase of 210.00 Cr..
- For CWIP, as of Sep 2025, the value is 129.00 Cr.. The value appears to be declining and may need further review. It has decreased from 212.00 Cr. (Mar 2025) to 129.00 Cr., marking a decrease of 83.00 Cr..
- For Investments, as of Sep 2025, the value is 272.00 Cr.. The value appears strong and on an upward trend. It has increased from 246.00 Cr. (Mar 2025) to 272.00 Cr., marking an increase of 26.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,380.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,297.00 Cr. (Mar 2025) to 1,380.00 Cr., marking an increase of 83.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,098.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,861.00 Cr. (Mar 2025) to 3,098.00 Cr., marking an increase of 237.00 Cr..
However, the Borrowings (989.00 Cr.) are higher than the Reserves (806.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -38.00 | 9.00 | 31.00 | 14.00 | -189.00 | -238.00 | -266.00 | -223.00 | -492.00 | -608.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 53 | 55 | 70 | 44 | 39 | 55 | 48 | 48 | 48 | 50 |
| Inventory Days | 45 | 52 | 57 | 61 | 75 | 94 | 91 | 96 | 129 | 92 |
| Days Payable | 135 | 146 | 180 | 114 | 131 | 159 | 163 | 141 | 154 | 147 |
| Cash Conversion Cycle | -36 | -39 | -53 | -9 | -17 | -9 | -24 | 3 | 22 | -6 |
| Working Capital Days | -58 | -54 | -57 | -49 | -78 | -75 | -60 | -38 | -49 | -44 |
| ROCE % | 19% | 24% | 22% | 17% | 8% | 11% | 19% | 17% | 16% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| HDFC Small Cap Fund | 435,082 | 0.64 | 244.11 | 432,935 | 2025-12-15 07:08:13 | 0.5% |
| HDFC Retirement Savings Fund - Hybrid Equity | 34,860 | 1.12 | 19.56 | N/A | N/A | N/A |
| LIC MF Value Fund | 7,309 | 2.01 | 4.1 | 5,035 | 2025-12-15 07:08:13 | 45.16% |
| Bandhan Transportation and Logistics Fund | 7,000 | 0.58 | 3.93 | 25,870 | 2025-12-15 02:23:09 | -72.94% |
| Navi Flexi Cap Fund | 5,500 | 1.16 | 3.09 | 10,500 | 2025-12-15 07:08:13 | -47.62% |
| Navi Aggressive Hybrid Fund | 2,299 | 1.02 | 1.29 | 4,299 | 2025-12-15 04:06:12 | -46.52% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 149.67 | 118.77 | 110.27 | 43.57 | 19.42 |
| Diluted EPS (Rs.) | 149.67 | 118.77 | 110.27 | 43.57 | 19.42 |
| Cash EPS (Rs.) | 190.93 | 155.92 | 151.15 | 104.54 | 86.78 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 828.32 | 718.41 | 624.30 | 526.06 | 492.56 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 828.32 | 718.41 | 624.30 | 526.06 | 492.56 |
| Revenue From Operations / Share (Rs.) | 3637.68 | 2820.58 | 2481.38 | 1873.52 | 1525.49 |
| PBDIT / Share (Rs.) | 308.75 | 258.66 | 237.64 | 158.72 | 133.20 |
| PBIT / Share (Rs.) | 187.55 | 159.33 | 152.15 | 90.61 | 64.18 |
| PBT / Share (Rs.) | 110.23 | 108.11 | 114.93 | 49.37 | 33.72 |
| Net Profit / Share (Rs.) | 69.73 | 56.59 | 65.66 | 36.43 | 17.77 |
| NP After MI And SOA / Share (Rs.) | 149.67 | 118.77 | 110.27 | 43.57 | 19.42 |
| PBDIT Margin (%) | 8.48 | 9.17 | 9.57 | 8.47 | 8.73 |
| PBIT Margin (%) | 5.15 | 5.64 | 6.13 | 4.83 | 4.20 |
| PBT Margin (%) | 3.03 | 3.83 | 4.63 | 2.63 | 2.21 |
| Net Profit Margin (%) | 1.91 | 2.00 | 2.64 | 1.94 | 1.16 |
| NP After MI And SOA Margin (%) | 4.11 | 4.21 | 4.44 | 2.32 | 1.27 |
| Return on Networth / Equity (%) | 18.06 | 16.53 | 17.66 | 8.28 | 3.94 |
| Return on Capital Employeed (%) | 14.30 | 13.76 | 17.86 | 12.80 | 10.68 |
| Return On Assets (%) | 4.89 | 4.26 | 5.52 | 2.63 | 1.33 |
| Long Term Debt / Equity (X) | 0.27 | 0.22 | 0.10 | 0.11 | 0.00 |
| Total Debt / Equity (X) | 0.99 | 0.88 | 0.65 | 0.74 | 0.65 |
| Asset Turnover Ratio (%) | 1.25 | 1.18 | 1.42 | 1.24 | 1.11 |
| Current Ratio (X) | 0.75 | 0.79 | 0.78 | 0.69 | 0.63 |
| Quick Ratio (X) | 0.44 | 0.41 | 0.42 | 0.39 | 0.35 |
| Inventory Turnover Ratio (X) | 6.22 | 3.63 | 4.79 | 4.63 | 4.29 |
| Dividend Payout Ratio (NP) (%) | 23.38 | 22.73 | 12.24 | 16.06 | 30.89 |
| Dividend Payout Ratio (CP) (%) | 12.92 | 12.38 | 6.89 | 6.26 | 6.78 |
| Earning Retention Ratio (%) | 76.62 | 77.27 | 87.76 | 83.94 | 69.11 |
| Cash Earning Retention Ratio (%) | 87.08 | 87.62 | 93.11 | 93.74 | 93.22 |
| Interest Coverage Ratio (X) | 3.99 | 5.05 | 7.57 | 6.93 | 4.37 |
| Interest Coverage Ratio (Post Tax) (X) | 1.90 | 2.10 | 3.28 | 3.39 | 1.58 |
| Enterprise Value (Cr.) | 3121.11 | 2795.80 | 2030.76 | 1175.94 | 1796.46 |
| EV / Net Operating Revenue (X) | 0.91 | 1.06 | 0.87 | 0.67 | 1.26 |
| EV / EBITDA (X) | 10.81 | 11.56 | 9.14 | 7.93 | 14.43 |
| MarketCap / Net Operating Revenue (X) | 0.69 | 0.85 | 0.71 | 0.47 | 1.05 |
| Retention Ratios (%) | 76.61 | 77.26 | 87.75 | 83.93 | 69.10 |
| Price / BV (X) | 3.05 | 3.34 | 2.84 | 1.68 | 3.26 |
| Price / Net Operating Revenue (X) | 0.69 | 0.85 | 0.71 | 0.47 | 1.05 |
| EarningsYield | 0.05 | 0.04 | 0.06 | 0.04 | 0.01 |
After reviewing the key financial ratios for Lumax Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 149.67. This value is within the healthy range. It has increased from 118.77 (Mar 24) to 149.67, marking an increase of 30.90.
- For Diluted EPS (Rs.), as of Mar 25, the value is 149.67. This value is within the healthy range. It has increased from 118.77 (Mar 24) to 149.67, marking an increase of 30.90.
- For Cash EPS (Rs.), as of Mar 25, the value is 190.93. This value is within the healthy range. It has increased from 155.92 (Mar 24) to 190.93, marking an increase of 35.01.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 828.32. It has increased from 718.41 (Mar 24) to 828.32, marking an increase of 109.91.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 828.32. It has increased from 718.41 (Mar 24) to 828.32, marking an increase of 109.91.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 3,637.68. It has increased from 2,820.58 (Mar 24) to 3,637.68, marking an increase of 817.10.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 308.75. This value is within the healthy range. It has increased from 258.66 (Mar 24) to 308.75, marking an increase of 50.09.
- For PBIT / Share (Rs.), as of Mar 25, the value is 187.55. This value is within the healthy range. It has increased from 159.33 (Mar 24) to 187.55, marking an increase of 28.22.
- For PBT / Share (Rs.), as of Mar 25, the value is 110.23. This value is within the healthy range. It has increased from 108.11 (Mar 24) to 110.23, marking an increase of 2.12.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 69.73. This value is within the healthy range. It has increased from 56.59 (Mar 24) to 69.73, marking an increase of 13.14.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 149.67. This value is within the healthy range. It has increased from 118.77 (Mar 24) to 149.67, marking an increase of 30.90.
- For PBDIT Margin (%), as of Mar 25, the value is 8.48. This value is below the healthy minimum of 10. It has decreased from 9.17 (Mar 24) to 8.48, marking a decrease of 0.69.
- For PBIT Margin (%), as of Mar 25, the value is 5.15. This value is below the healthy minimum of 10. It has decreased from 5.64 (Mar 24) to 5.15, marking a decrease of 0.49.
- For PBT Margin (%), as of Mar 25, the value is 3.03. This value is below the healthy minimum of 10. It has decreased from 3.83 (Mar 24) to 3.03, marking a decrease of 0.80.
- For Net Profit Margin (%), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 5. It has decreased from 2.00 (Mar 24) to 1.91, marking a decrease of 0.09.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 4.11. This value is below the healthy minimum of 8. It has decreased from 4.21 (Mar 24) to 4.11, marking a decrease of 0.10.
- For Return on Networth / Equity (%), as of Mar 25, the value is 18.06. This value is within the healthy range. It has increased from 16.53 (Mar 24) to 18.06, marking an increase of 1.53.
- For Return on Capital Employeed (%), as of Mar 25, the value is 14.30. This value is within the healthy range. It has increased from 13.76 (Mar 24) to 14.30, marking an increase of 0.54.
- For Return On Assets (%), as of Mar 25, the value is 4.89. This value is below the healthy minimum of 5. It has increased from 4.26 (Mar 24) to 4.89, marking an increase of 0.63.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.27. This value is within the healthy range. It has increased from 0.22 (Mar 24) to 0.27, marking an increase of 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.99. This value is within the healthy range. It has increased from 0.88 (Mar 24) to 0.99, marking an increase of 0.11.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.25. It has increased from 1.18 (Mar 24) to 1.25, marking an increase of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 0.75. This value is below the healthy minimum of 1.5. It has decreased from 0.79 (Mar 24) to 0.75, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has increased from 0.41 (Mar 24) to 0.44, marking an increase of 0.03.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.22. This value is within the healthy range. It has increased from 3.63 (Mar 24) to 6.22, marking an increase of 2.59.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 23.38. This value is within the healthy range. It has increased from 22.73 (Mar 24) to 23.38, marking an increase of 0.65.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 12.92. This value is below the healthy minimum of 20. It has increased from 12.38 (Mar 24) to 12.92, marking an increase of 0.54.
- For Earning Retention Ratio (%), as of Mar 25, the value is 76.62. This value exceeds the healthy maximum of 70. It has decreased from 77.27 (Mar 24) to 76.62, marking a decrease of 0.65.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.08. This value exceeds the healthy maximum of 70. It has decreased from 87.62 (Mar 24) to 87.08, marking a decrease of 0.54.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.99. This value is within the healthy range. It has decreased from 5.05 (Mar 24) to 3.99, marking a decrease of 1.06.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.90. This value is below the healthy minimum of 3. It has decreased from 2.10 (Mar 24) to 1.90, marking a decrease of 0.20.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,121.11. It has increased from 2,795.80 (Mar 24) to 3,121.11, marking an increase of 325.31.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.91. This value is below the healthy minimum of 1. It has decreased from 1.06 (Mar 24) to 0.91, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 10.81. This value is within the healthy range. It has decreased from 11.56 (Mar 24) to 10.81, marking a decrease of 0.75.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.69, marking a decrease of 0.16.
- For Retention Ratios (%), as of Mar 25, the value is 76.61. This value exceeds the healthy maximum of 70. It has decreased from 77.26 (Mar 24) to 76.61, marking a decrease of 0.65.
- For Price / BV (X), as of Mar 25, the value is 3.05. This value exceeds the healthy maximum of 3. It has decreased from 3.34 (Mar 24) to 3.05, marking a decrease of 0.29.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.69. This value is below the healthy minimum of 1. It has decreased from 0.85 (Mar 24) to 0.69, marking a decrease of 0.16.
- For EarningsYield, as of Mar 25, the value is 0.05. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.05, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Lumax Industries Ltd:
- Net Profit Margin: 1.91%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 14.3% (Industry Average ROCE: 20.43%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 18.06% (Industry Average ROE: 15.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.9
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 29 (Industry average Stock P/E: 51.63)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.99
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.91%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Auto Ancl - Equipment Lamp | 2nd Floor, Harbans Bhawan-II, New Delhi Delhi 110046 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dhanesh Kumar Jain | Chairman Emeritus |
| Mr. Deepak Jain | Chairman & Managing Director |
| Mr. Anmol Jain | Joint Managing Director |
| Mr. Tadayoshi Aoki | Senior Executive Director |
| Mr. Raajesh Kumar Gupta | Executive Director |
| Mr. Kenjiro Nakazono | Executive Director |
| Mr. Tomohiro Kondo | Non Executive Director |
| Mr. Rajeev Kapoor | Independent Director |
| Ms. Ritika Sethi | Independent Director |
| Mr. Vikrampati Singhania | Independent Director |
| Mr. Harish Lakshman | Independent Director |
| Mr. Pradeep Singh Jauhar | Independent Director |
| Ms. Pallavi Dinodia Gupta | Independent Director |
FAQ
What is the intrinsic value of Lumax Industries Ltd?
Lumax Industries Ltd's intrinsic value (as of 23 January 2026) is ₹5107.36 which is 10.24% higher the current market price of ₹4,633.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹4,337 Cr. market cap, FY2025-2026 high/low of ₹5,878/1,960, reserves of ₹806 Cr, and liabilities of ₹3,098 Cr.
What is the Market Cap of Lumax Industries Ltd?
The Market Cap of Lumax Industries Ltd is 4,337 Cr..
What is the current Stock Price of Lumax Industries Ltd as on 23 January 2026?
The current stock price of Lumax Industries Ltd as on 23 January 2026 is ₹4,633.
What is the High / Low of Lumax Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Lumax Industries Ltd stocks is ₹5,878/1,960.
What is the Stock P/E of Lumax Industries Ltd?
The Stock P/E of Lumax Industries Ltd is 29.0.
What is the Book Value of Lumax Industries Ltd?
The Book Value of Lumax Industries Ltd is 873.
What is the Dividend Yield of Lumax Industries Ltd?
The Dividend Yield of Lumax Industries Ltd is 0.76 %.
What is the ROCE of Lumax Industries Ltd?
The ROCE of Lumax Industries Ltd is 16.4 %.
What is the ROE of Lumax Industries Ltd?
The ROE of Lumax Industries Ltd is 19.3 %.
What is the Face Value of Lumax Industries Ltd?
The Face Value of Lumax Industries Ltd is 10.0.